The government has announced a fast-track approval process for generic medicines, aiming to bring cheaper versions of widely used treatments to pharmacies within months rather than years. The health ministry estimates the change could cut the public health system’s annual drug bill by about 8 percent, a saving worth several hundred million, once the new rules are fully in place.
Generic medicines contain the same active ingredient as the original product and must meet the same quality standards, but are usually sold at a fraction of the price once patents expire. Under the current system, applications can wait for more than two years. The new process sets a target of 180 days for most submissions, with extra inspectors hired to meet it.
Patient groups welcomed the announcement, saying cost is a real barrier for people who take several medicines every day. A representative of one such group said families sometimes skip pharmacy visits when money is tight. ‘Lower prices are not a luxury. They decide whether people can stay on the treatment their doctor has recommended,’ the representative said.
Manufacturers of original products have voiced concern, arguing that predictable patent protection encourages investment in new research. A spokesperson for an industry association said the group supported faster approvals in principle but wanted guarantees that safety checks would not be weakened. Ministry officials said inspection standards would not change and that every approved product would be monitored after reaching the market.
Pharmacists will be allowed to offer an approved generic whenever a doctor’s prescription names only the active ingredient, and patients can decline. The first products to be fast-tracked are expected to include treatments for high blood pressure and diabetes. Parliament is due to vote on the supporting legislation before the end of the year.











Leave a Reply